ImpediMed has received $15m in funding for five years from SWK Holdings, which is set to enhance its ability to grow and ...

SWK Holdings’ baby bond, trading slightly above par, offers an attractive return for income investors despite a potential short-duration call opportunity. The company’s year-to-date revenue ...

CARLSBAD, Calif. - ImpediMed, known for its medical technology in fluid and body composition monitoring, has secured a five-year $15 million growth capital facility with SWK Holdings Corporation ...

DALLAS, TX / ACCESSWIRE / January 6, 2025 / SWK Holdings Corporation (NASDAQ:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small- and mid-sized ...

SWK Holdings Corp. engages in financial and asset management in the field of pharmaceuticals. The company offers capital and investments in life science companies, institutions, and inventors.

Lisa Levin SWK Holdings Says On Dec. 27, Carlson Capital Delivered To Members Of Co's Special Committee Updated Terms Of Proposed Transaction; Carlson To Acquire All Shares Of SWK Holdings For $20 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Equities researchers at Zacks Research upped their Q1 2026 earnings per share estimates for shares of Stanley Black & Decker ...

SWK Holdings Corporation (NASDAQ:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small- and mid-sized commercial-stage companies, provided today a ...

SWK continues to hold Moleculight preferred equity, which is carried at no value on SWK's balance sheet. About SWK Holdings Corporation SWK Holdings Corporation is a life science focused specialty ...